← Evidence map

ArticleOncotarget2015

miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma.

Lei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26287602